Finally, in patients with CKD, a loss of the anti-inflammatory activity of HDL has been reported, explained at least in part by the enrichment in acute-phase proteins, such as SAA [43], and in apoC-III, involved in the activation of inflammatory cell response and organ damage by alternative inflammasome activation [44] (Figure 1). Here, APOC3 is linked to chronic kidney disease.